Proteome Sciences plc (LSE: PRM) Stock Analysis & Fundamentals | ScreenerHero

Create free account

PRMProteome Sciences plc

LSE · GB · Healthcare · Diagnostics & Research · proteomics.com

2.000GBp+2.56%Mkt Cap: 7.43M $P/E: —2d ago

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The compa…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap7.43M $

Enterprise Value23.73M $

Revenue (TTM)4.08M $

Gross Profit-88.04K $

Net Income (TTM)-3.33M $

Revenue/Share0.0141 USD

Last Price2.000 GBp

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees32

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-8.78

EV/Revenue5.81

P/S1.82

P/B-0.61

EPS (TTM)-0.01

EPS (Forward)—

52W Range

1.20025% of range4.400

52W High4.400 GBp

52W Low1.200 GBp

Profitability

Gross Margin-2.16%

Oper. Margin-54.98%

EBITDA Margin-66.19%

Profit Margin-81.50%

ROE32.12%

ROA-37.08%

Growth

Revenue Growth-28.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-50.00K $

CapEx (TTM)105.43K $

FCF Margin-10.15%

FCF Yield-5.58%

Net Debt16.29M $

Net Debt/EBITDA-6.03

Balance Sheet

Debt/Equity-1.65

Current Ratio0.13

Quick Ratio0.09

Book Value/Sh-0.0320 GBp

Cash/Share0.0020 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.350.72M

Float221.68M

Insiders18.08%

Institutions24.22%

Technical

SMA 501.639 (+22.0%)

SMA 2001.887 (+6.0%)

Beta0.15

S&P 52W Chg20.25%

Avg Vol (30d)199.66K

Avg Vol (10d)283.15K

Technical Indicators

RSI (14)60.8

MACD0.0827

MACD Signal0.0430

MACD Hist.+0.0397

BB Upper2.018 GBp

BB Middle1.676 GBp

BB Lower1.334 GBp

BB Width40.77%

ATR (14)0.4836 GBp

Vol Ratio (20d)0.00x